C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
03/2006
03/23/2006	WO2006030956A1 NOVEL USE OF PrPP AND RECEPTOR THEREOF
03/23/2006	WO2006030887A1 External preparation for treating skin ulcer
03/23/2006	WO2006030872A1 Method and apparatus for measuring mutation ratio
03/23/2006	WO2006030866A1 Method of quantitative determination of uric acid
03/23/2006	WO2006030846A1 Method of estimating the secondary processing properties of wheat in growth stage
03/23/2006	WO2006030802A1 Method of screening baff suppressor or inhibitor
03/23/2006	WO2006030788A1 Intercalator and method of gene detection using the same
03/23/2006	WO2006030761A1 Novel diabetes-associated factor
03/23/2006	WO2006030455A1 Dna polymerases having strand displacement activity
03/23/2006	WO2006030270A1 Method and kit for assessing dna fragmentation following exposure
03/23/2006	WO2006030237A1 Tissue-specific transcription by rna polymerase iii
03/23/2006	WO2006030174A1 Dna polymerase
03/23/2006	WO2006030126A2 Method of accelerating somatic mutations and use thereof in proteomics
03/23/2006	WO2006030119A1 Novel enzymatic substrates derived from phenoxazinone and their use as developer in detection of micro-organism with peptidase activity
03/23/2006	WO2006030071A2 Methods for the utilization of novel target genes related to immune-mediated diseases
03/23/2006	WO2006029591A1 Sensor arrangement and method for detecting a sensor event
03/23/2006	WO2006020755A9 Methods for identifying inhibitors of the mtor pathway as diabetes therapeutics
03/23/2006	WO2006020748A2 Gfp-snap25 fluorescence release assay for botulinum toxin protease activity
03/23/2006	WO2006010494A3 Diagnostics and therapeutics for diseases associated with methionine aminopeptidase 1 (metapi)
03/23/2006	WO2006000829A3 Electrochemical sensing method
03/23/2006	WO2006000828A3 Electrode for electrochemical sensor
03/23/2006	WO2005123945A3 Epigenetic markers for the treatment of breast cancer
03/23/2006	WO2005121358A3 Extendable probes
03/23/2006	WO2005121354A3 Peptide substrates recognisable by a botulinum toxin a, bont/a and the use thereof
03/23/2006	WO2005116245A3 Cdna production from cells after laser microdissection
03/23/2006	WO2005113835A3 Kits and methods for indentification, assessment, prevention and therapy of breast cancer
03/23/2006	WO2005113788A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor kinase 6 (grk6)
03/23/2006	WO2005113147A3 Integration of sample storage and sample management for life science
03/23/2006	WO2005107396A3 Novel compositions and methods in cancer
03/23/2006	WO2005100602A3 Biosensor based on directed assembly of particles
03/23/2006	WO2005099774A3 Diagnosis and treatment of myeloid and lymphoid cell cancers
03/23/2006	WO2005098051A3 Hsv-2 type-specific immunoassays using glycoprotein g2 peptides
03/23/2006	WO2005098040A3 Ligation and amplification reactions for determining target molecules
03/23/2006	WO2005098025A3 High throughput reactive oxygen species-based cytochrome p450 inhibition assay
03/23/2006	WO2005095987A3 Salivary soluble cd44: a molecular marker for head and neck cancer
03/23/2006	WO2005095975A3 Anti-fungal target genes
03/23/2006	WO2005083122A3 Method for detecting a microorganism in a fecal specimen
03/23/2006	WO2005080983A3 Using liquid crystals to detect affinity microcontact printed biomolecules
03/23/2006	WO2005078139A3 DIAGNOSIS AND TREATMENT OF CANCERS WITH MicroRNA LOCATED IN OR NEAR CANCER-ASSOCIATED CHROMOSOMAL FEATURES
03/23/2006	WO2005071095A3 Fluorogenic kinase assays and substrates for kinases and phosphatases
03/23/2006	WO2005062706A3 Methods of predicting a benefit of antioxidant therapy for prevention of cardiovascular disease in hyperglycemic patients
03/23/2006	WO2005060344A3 Direct identification and mapping of rna transcripts
03/23/2006	WO2005059111A3 DELIVERY OF DNA OR RNA VIA GAP JUNCTIONS FROM HOST CELLS TO TARGET CELLS AND A CELL-BASED DELIVERY SYSTEM FOR ANTISENSE OR SiRNA
03/23/2006	WO2005058006A3 Methods and compositions comprising bacteriophage nanoparticles
03/23/2006	WO2005052131A3 C140rf35 as modifier of the beta catenin pathway and methods of use
03/23/2006	WO2005049794A3 Methods of characterizing infectious bursal disease virus
03/23/2006	WO2005047459A3 Sars nucleic acids, proteins, antibodies, and uses thereof
03/23/2006	WO2005046585A3 Vps35-based assays and methods for treating alzheimer’s disease
03/23/2006	WO2005041903A3 Methods and reagents for diagnosis and treatment of diabetes
03/23/2006	WO2005035549A3 Amiphiphylic peptide-pna conjugates for the delivery of pna through the blood brain barrier
03/23/2006	WO2005033125A3 Mammalian t1r3 sweet taste receptors
03/23/2006	WO2005019251A3 Novel fungal proteins and nucleic acids encoding same
03/23/2006	WO2005018431A3 Compositions and methods for detecting and treating neurological conditions
03/23/2006	WO2005017804A3 Methods and system for multi-drug treatment discovery
03/23/2006	WO2005013886A3 Methods for treating and preventing apoptosis-related diseases using rna interfering agents
03/23/2006	WO2005007816A3 Compositions and methods for identifying an individual organism based on single nucleotide polymorphisms
03/23/2006	WO2005007623A8 Inhibition of syk kinase expression
03/23/2006	WO2004110244A3 A gene equation to diagnose rheumatoid arthritis
03/23/2006	WO2004108939A3 BAV packaging regions and E1 transcriptional control regions
03/23/2006	WO2004104214A3 Methods and devices for multiplexing amplification reactions
03/23/2006	WO2004081537A3 Methods of evaluating caloric restriction and identifying caloric restriction mimetics
03/23/2006	WO2004065563A3 Ndr kinase modulators
03/23/2006	WO2004064987A3 Method
03/23/2006	WO2004064537A3 Method for the in situ production of an emulsifier in foodstuff
03/23/2006	WO2004061088A3 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
03/23/2006	WO2004056970A3 Chemo-enzymatic process for proteome-wide mapping of post-translational modification
03/23/2006	WO2004011618A3 Methods of identifying adipocyte specific genes, the genes identified, and their uses
03/23/2006	WO2004006753A3 Sga-72m, a cancer associated antigen, and uses thereof
03/23/2006	WO2003082202A3 Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases
03/23/2006	US20060064778 Using vector transformation to insert plasmid which express antisense sequences which reduce proanthocyanidin (PA) in plant seed coats; enhancing feed quality and digestibility
03/23/2006	US20060064765 Obesity gene
03/23/2006	US20060064035 Multiple-biosensor article
03/23/2006	US20060063925 solid phase; comprising a solid support having a tag oligonucleotide covalently bound to the surface of the solid support; immobilization; re-usable anchoring system for nucleic acid molecules; employed in high throughput and/or automated systems
03/23/2006	US20060063922 Epidermal differentiation factor
03/23/2006	US20060063795 SNS-595 and methods of using the same
03/23/2006	US20060063736 Compositions and methods for inhibiting mucin-type O-linked glycosylation
03/23/2006	US20060063734 4,7-dichlorofluorescein dyes as molecular probes
03/23/2006	US20060063731 In vivo inhibition of hepatitis B virus
03/23/2006	US20060063727 Tr4/tr2 response elements
03/23/2006	US20060063710 Flj20647s as modifiers of the p21 pathway and methods of use
03/23/2006	US20060063709 Nuclear factors associated with transcriptional regulation
03/23/2006	US20060063248 Butyrylcholinesterase variants and methods of use
03/23/2006	US20060063244 Comprises ribonuclease barnase marker gene; libraries; drug resistance
03/23/2006	US20060063235 DNA encoding the human serine protease C-E
03/23/2006	US20060063230 Sulfatases and methods of use thereof
03/23/2006	US20060063225 Novel procedure for growth, imaging, and enumeration of microbial colonies for serological or screening assays
03/23/2006	US20060063224 Method for the identification and treatment of pathogenic microorganism infections by inhibiting one or more enzymes in an essential metabolic pathway
03/23/2006	US20060063223 Drug screening; C-C-chemokine receptor 1 (CCR1); inflammatory diseases; identifying potential inhibitor of chemoattractant receptor activity
03/23/2006	US20060063222 Treating with a sample, under conditions suitable for clostridial toxin protease activity; exciting the fluorophore with plane polarized light; and determining fluorescence polarization of the treated substrate
03/23/2006	US20060063221 Lanthanide-based substrates and methods for determining clostridial toxin activity
03/23/2006	US20060063220 Charcoal stabilization of phenyl phosphates
03/23/2006	US20060063219 Trivalent metal mediated homogeneous luminescent proximity assay
03/23/2006	US20060063218 Micropressors, devices and methods for use in analyte monitoring systems
03/23/2006	US20060063217 Coenzyme-binding glucose dehydrogenase
03/23/2006	US20060063215 Human GAK-related gene variants associated with lung cancer
03/23/2006	US20060063210 Histone deacetylase whole cell enzyme assay
03/23/2006	US20060063204 such as annexins, natrietic precursor protein, and enolase; high speed immunoassay; for early detection and differentiation of stable/unstable angina and myocardial infarction
03/23/2006	US20060063203 Vascular endothelial cell growth factor variants and uses thereof
03/23/2006	US20060063196 the specific binding pair member is generally bonded to the bar code through a linking group; bar code may be read during translocation through a single nano-meter scale pore; screening and diagnostic applications.
03/23/2006	US20060063195 Binding surface

1 ... 1583 1584 1585 1586 1587 1588 1589 1590 1591 1592 1593 1594 1595 1596 1597 1598 1599 1600 1601 1602 1603 ... 3003